• Insan Sunan Kurniawansyah Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy Padjadjaran University, Indonesia
  • Iyan Sopyan


Context: In situ gel forming system is applied as eye drops which can undergo a transition from solution to gel. The advantage of in situ gel can be to maximize absorption of the drug in the eye and minimize drug loss before corneal penetration.

Aims: The purpose of this study was to find out the isotonicity of chloramphenicol ophthalmic in situ gel and to know the irritating effect of its in the eyes of test animals.

Settings and Design: This study were started by making four aseptic formulations of in situ gel preparations with a comparison of the baseline concentrations of different Poloxamer 407 and HPMC, F1 (5: 0.45), F2 (10: 0.45), F3 (5 : 1) and F4 (10: 1).

Methods : Four aseptic of in situ gel preparations, followed by a qualitative isotonicity test using blood cells to see the comparison between control and test preparations, and ocular irritation test using the draize test method to determine the presence or absence of the irritation.

Materials : Chloramphenicol, hydroxypropyl methylcellulose, poloxamer 407, propylene glycol, potassium dihydrogen phosphate, sodium hydroxide,  ethanol and aqua bidestilata sterile.

Statistical analysis used: Descriptive

Results: The results obtained from the isotonicity test showed that blood cells that had been dripped with the test preparations were then observed under a microscope showing normal results and the results of the ocular irritation test using the draize test method showed zero values on each test parameter.

Conclusions: Chloramphenicol in situ gel are isotonic and do not cause irritation to the rabbit's eyes, so they are safe to use.

Keywords: chloramphenicol, HPMC, in situ gel, poloxamer 407, isotonicity, ocular irritation, draize test.


1. Thamizhvanan K, Himabindu R, Sarada K, Hyndavi, N, Roopa KL. Current status and advanced approaches in ocular drug delivery systems. Int J Curr Pharm Clin Res 2012; 2:77-86.
2. Sonawane SD, Patil RY, Lad M. A review on polymers used in novel in situ gel formulation for ocular drug delivery and their evaluation. J Biol Sci Opin 2013;1:132-7.
3. Nagaich U, Jain N, Kumar D, Gulati N. Controlled ocular drug delivery of ofloxacin using temperature modulated in situ gelling system. J Sci Soc 2013;40:90-4.
4. Kurniawansyah IS, Sopyan I, Wathoni N, Fillah DL, Praditya RU. Application and characterization of in situ gel. Int J App Pharm 2018;10:34-7.
5. Shetty GN and Charyulu RN. A study on stability and in vivo drug release of naphazoline and antazoline in situ gelling systems for ocular delivery. Int J Pharm Bio Sci 2013:4:161-71.
6. Dasankoppa FS, Kujur S, Ahmed Sholapur HP, Jamakandi VG. Design, formulation and evaluation of carboxy methyl tamarind based in situ gelling ophthalmic drug delivery system of dorzolamide hydrochloride. Indian J Health Sci 2016;9:56-66.
7. Champalal KD and Poddar SS. Current status of ophthalmic in situ forming hydrogel. Int J Pharm Bio Sci 2012;3:372-88.
8. Bachhav HD, Savkare A, Karmarkar R, Derle D. Development of poloxamer based thermosensitive in situ ocular gel of betaxolol hydrochloride. Int J Pharm Pharm Sci 2015;7: 287-91.
9. Montgomery DC. Design and analysis of experiments. 8th ed. Hoboken: John Wiley & Sons Inc. 2013.
10. Giuliano E, Paolino D, Fresta M, Cosco D. Mucosal applications of poloxamer 407-based hydrogels: An overview. Pharmaceutics 2018;10:1-26.
11. Dasankoppa FS, Hiremath SP, Nadaf A. Formulation and evaluation of a novel in situ gum based ophthalmic drug delivery system of linezolid. Sci Pharm 2008;76:515?32.
12. Remington. The Science & Practice of Pharmacy. 21st ed., Vol. II. Philadelphia, PA Lippincott Williams & Wilkins; 2005.
13. Saini R, Seema S, Singh G, Banerjee A. in situ gels – a new trends in ophthalmic drug delivery systems. Int J Pharm Sci Res 2015;6:886-90.
14. Dasankoppa FS, Swamy NG. Design, development and evaluation of cationic guar and hydroxypropyl guar based In situ gels for ophthalmic drug delivery. Indian Drugs 2013;50:30?40.
15. Rajas NJ, Kavitha K. Sustained ophthalmic delivery of levofloxacin hemihydrate from an ion activated in situ gelling system. Int J Pharm Tech Res 2011;3:702 6.
16. Wilhelmus KR. The Draize eye test. Surv Ophthalmol 2001;45:493 515.
17. Kepala Badan Pengawas Obat Dan Makanan Republik Indonesia. Peraturan Kepala Badan Pengawas Obat Dan Makanan Republik Indonesia Nomor 7 Tahun 2014 Tentang Pedoman Uji Toksisitas Nonklinik Secara In Vivo. 2014.
18. OECD/OCDE. OECD Guideline For The Testing of Chemicals: Acute Eye Irritation/ Corrosion. 2012.
19. Nayak NS, Bharani SS, Thakur RS. Formulation and evaluation of pH triggered in situ ophthalmic gel of moxifloxacin hydrochloride. Int J Pharm Pharm Sci 2012;4:452-9.
20. Champalal KD, Poddar SS. Current status of an ophthalmic in situ forming hydrogel. Int J Pharm Bio Sci 2012;3:372-88.
21. Azita H, Talasaz H, Ali AG, Shadi HM, Mazda RM, Atyabi F, Dinarvand R. In situ gel forming systems of poloxamer 407 and hydroxypropyl cellulose or hydroxypropyl methyl cellulose mixtures for controlled delivery of vancomycin. J Appl Polym Sci 2008:2369-74.
22. Makwana SB, Patel VA, Parmar. Development and characterization of in situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results in Pharma Sciences 2016;6:1–6.
23. Barse R, Kokare C, Tagalpallewar A. Influence of hydroxypropylmethylcellulose and poloxamer composite on developed ophthalmic in situ gel: Ex vivo and in vivo characterization. Journal of Drug Delivery Science and Technology 2016:1-29.
16 Views | Downloads
How to Cite
Kurniawansyah, I. S., & Iyan Sopyan. (2020). STUDY OF ISOTONICITY AND OCULAR IRRITATION OF CHLORAMPHENICOLE IN SITU GEL. International Journal of Applied Pharmaceutics, 13(1). Retrieved from
Original Article(s)